NAT10 and pachyonychia congenita: In conclusion, this study established NAT10 as a central regulator of PC progression and immune evasion through the ac4C-dependent stabilization of ETS2 and KRT8 mRNA, thereby promoting tumor immunosuppression and malignancy.